Onconetix, Inc. (ONCO) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Onconetix, Inc. (ONCO) closed at USD 0.55 on 2026-10-14, a change of -99.7 % over the past year, with a market capitalization of USD 2.87M.

Onconetix, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Onconetix, Inc. key figures

Previous close

USD 0.55 (2026-10-14)

1-year change

-99.7 %

Market cap

USD 2.87M

Enterprise value

USD -3.59M

P/E ratio (trailing)

0.00

P/E ratio (forward)

-0.65

EPS (trailing)

310.39

EPS (forward)

-0.85

PEG ratio

n/a

Price to book

0.15

Revenue growth

-83.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.09

Employees

2

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Onconetix, Inc.

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Onconetix, Inc. and compare it with other stocks.